Page last updated: 2024-08-24

dolomite and Glaucoma, Suspect

dolomite has been researched along with Glaucoma, Suspect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Boyer, JL; Duquesroix, B; Fechtner, RD; Kothe, AC; Lopez, K; Navratil, T; Usner, DW; Walters, TR	1

Trials

1 trial(s) available for dolomite and Glaucoma, Suspect

Article	Year
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study. Journal of glaucoma, 2022, 06-01, Volume: 31, Issue:6 Topics: Adult; Antihypertensive Agents; Calcium Carbonate; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Magnesium; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Treatment Outcome	2022

Article

Year

A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study.

Journal of glaucoma, 2022, 06-01, Volume: 31, Issue:6

Topics: Adult; Antihypertensive Agents; Calcium Carbonate; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Magnesium; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Treatment Outcome

2022